You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 247 No. 3, January 15, 1982 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Bromocriptine Reduces Pituitary Tumor Size and Hypersecretion

Requiem for Pituitary Surgery?

Richard F. Spark, MD; Richard Baker, MD; Don C. Bienfang, MD; Richard Bergland, MD

JAMA. 1982;247(3):311-316.


Abstract

Twelve patients with pituitary tumor whose prior treatment included surgery and radiotherapy in four, surgery alone in four, radiotherapy alone in one, and none in three were studied. Nine had hyperprolactinemia, two had elevated serum growth hormones, and one had no pituitary hormone excess. Visual field defects were present in six. All had pituitary-gonadal insufficiency manifested as impotence or amenorrhea. All were treated with bromocriptine, 7.5 to 25 mg daily, and followed up for eight to 27 ([unk] 15) months. Serum prolactin levels decreased to normal in seven of nine patients. Serum growth hormone values were normalized in both acromegalics. When hormone levels were reduced to normal, pituitary tumor size decreased. Vision was restored to normal in five of six patients, including one patient with pituitary tumor but no pituitary hormone excess. Bromocriptine corrects the physiological defects associated with pituitary tumors that have been incompletely treated with surgery, radiotherapy, or both and may be a useful primary treatment for patients with pituitary tumors.

(JAMA 1982;247:311-316)



Author Affiliations

From the Department of Medicine and Surgery, Beth Israel Hospital (Drs Spark and Bergland), the Department of Radiology, Lahey Clinic (Dr Baker), and the Department of Ophthalmology, Brigham and Women's Hospital (Dr Bienfang), Boston.


Footnotes

Presented in part at the 50th annual meeting of the American Association of Neurologic Surgeons, Boston, April 7, 1981.

Reprint requests to the Steroid Research Laboratory, Beth Israel Hospital, 330 Brookline Ave, Boston, MA 02215 (Dr Spark).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Bromocriptine Treatment of Prolactin-Secreting Pituitary Adenomas May Restore Pituitary Function
WARFIELD et al.
ANN INTERN MED 1984;101:783-785.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1982 American Medical Association. All Rights Reserved.